United States Newcastle Disease Vaccine Market Report & Forecast 2021-2027

United States Newcastle Disease Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Newcastle Disease Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Newcastle Disease Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Newcastle Disease Vaccine Overall Market Size
2.1 United States Newcastle Disease Vaccine Market Size: 2021 VS 2027
2.2 United States Newcastle Disease Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Newcastle Disease Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Newcastle Disease Vaccine Players in United States Market
3.2 Top United States Newcastle Disease Vaccine Companies Ranked by Revenue
3.3 United States Newcastle Disease Vaccine Revenue by Companies
3.4 United States Newcastle Disease Vaccine Sales by Companies
3.5 United States Newcastle Disease Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Newcastle Disease Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Newcastle Disease Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Newcastle Disease Vaccine Players in United States Market
3.8.1 List of Tier 1 Newcastle Disease Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Newcastle Disease Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Newcastle Disease Vaccine Market Size Markets, 2021 & 2027
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type - United States Newcastle Disease Vaccine Revenue & Forecasts
4.2.1 By Type - United States Newcastle Disease Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Newcastle Disease Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Newcastle Disease Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Newcastle Disease Vaccine Sales & Forecasts
4.3.1 By Type - United States Newcastle Disease Vaccine Sales, 2016-2021
4.3.2 By Type - United States Newcastle Disease Vaccine Sales, 2022-2027
4.3.3 By Type - United States Newcastle Disease Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Newcastle Disease Vaccine Market Size, 2021 & 2027
5.1.2 Chicken
5.1.3 Duck & Goose
5.1.4 Other
5.2 By Application - United States Newcastle Disease Vaccine Revenue & Forecasts
5.2.1 By Application - United States Newcastle Disease Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Newcastle Disease Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Newcastle Disease Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Newcastle Disease Vaccine Sales & Forecasts
5.3.1 By Application - United States Newcastle Disease Vaccine Sales, 2016-2021
5.3.2 By Application - United States Newcastle Disease Vaccine Sales, 2022-2027
5.3.3 By Application - United States Newcastle Disease Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Overview
6.1.3 Merial Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 Merial Newcastle Disease Vaccine Product Description
6.1.5 Merial Recent Developments
6.2 CEVA
6.2.1 CEVA Corporation Information
6.2.2 CEVA Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 CEVA Newcastle Disease Vaccine Product Description
6.2.5 CEVA Recent Developments
6.3 QYH Biotech
6.3.1 QYH Biotech Corporation Information
6.3.2 QYH Biotech Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Description
6.3.5 QYH Biotech Recent Developments
6.4 Ringpu Biology
6.4.1 Ringpu Biology Corporation Information
6.4.2 Ringpu Biology Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Description
6.4.5 Ringpu Biology Recent Developments
6.5 Yebio
6.5.1 Yebio Corporation Information
6.5.2 Yebio Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Yebio Newcastle Disease Vaccine Product Description
6.5.5 Yebio Recent Developments
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Corporation Information
6.6.2 Harbin Veterinary Research Institute Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Description
6.6.5 Harbin Veterinary Research Institute Recent Developments
6.7 Merck Animal Health
6.7.1 Merck Animal Health Corporation Information
6.7.2 Merck Animal Health Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Description
6.7.5 Merck Animal Health Recent Developments
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Overview
6.8.3 DHN Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.8.4 DHN Newcastle Disease Vaccine Product Description
6.8.5 DHN Recent Developments
6.9 Zoetis
6.9.1 Zoetis Corporation Information
6.9.2 Zoetis Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.9.4 Zoetis Newcastle Disease Vaccine Product Description
6.9.5 Zoetis Recent Developments
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Corporation Information
6.10.2 ChengDu Tecbond Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Description
6.10.5 ChengDu Tecbond Recent Developments
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Corporation Information
6.11.2 Elanco (Lohmann) Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Description
6.11.5 Elanco (Lohmann) Recent Developments
6.12 FATRO
6.12.1 FATRO Corporation Information
6.12.2 FATRO Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.12.4 FATRO Newcastle Disease Vaccine Product Description
6.12.5 FATRO Recent Developments
6.13 CAVAC
6.13.1 CAVAC Corporation Information
6.13.2 CAVAC Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.13.4 CAVAC Newcastle Disease Vaccine Product Description
6.13.5 CAVAC Recent Developments
6.14 Vaksindo
6.14.1 Vaksindo Corporation Information
6.14.2 Vaksindo Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales and Revenue in United States Market (2016-2021)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Description
6.14.5 Vaksindo Recent Developments
7 United States Newcastle Disease Vaccine Production Capacity, Analysis
7.1 United States Newcastle Disease Vaccine Production Capacity, 2016-2027
7.2 Newcastle Disease Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Newcastle Disease Vaccine Supply Chain Analysis
9.1 Newcastle Disease Vaccine Industry Value Chain
9.2 Newcastle Disease Vaccine Upstream Market
9.3 Newcastle Disease Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Newcastle Disease Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Newcastle Disease Vaccine in United States Market
Table 2. Top Newcastle Disease Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Newcastle Disease Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Newcastle Disease Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Newcastle Disease Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Newcastle Disease Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Newcastle Disease Vaccine Price (2016-2021) & (USD/K Doses)
Table 8. Manufacturers Newcastle Disease Vaccine Product Type
Table 9. List of Tier 1 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Live Vaccines
Table 12. Major Manufacturers of Killed Vaccines
Table 13. By Type - United States Newcastle Disease Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Newcastle Disease Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Newcastle Disease Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Newcastle Disease Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Newcastle Disease Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Newcastle Disease Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Newcastle Disease Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Newcastle Disease Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Newcastle Disease Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Newcastle Disease Vaccine Sales (M Doses), 2022-2027
Table 23. Merial Corporation Information
Table 24. Merial Description and Major Businesses
Table 25. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 26. Merial Newcastle Disease Vaccine Product
Table 27. Merial Recent Developments
Table 28. CEVA Corporation Information
Table 29. CEVA Description and Major Businesses
Table 30. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 31. CEVA Newcastle Disease Vaccine Product
Table 32. CEVA Recent Developments
Table 33. QYH Biotech Corporation Information
Table 34. QYH Biotech Description and Major Businesses
Table 35. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 36. QYH Biotech Newcastle Disease Vaccine Product
Table 37. QYH Biotech Recent Developments
Table 38. Ringpu Biology Corporation Information
Table 39. Ringpu Biology Description and Major Businesses
Table 40. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 41. Ringpu Biology Newcastle Disease Vaccine Product
Table 42. Ringpu Biology Recent Developments
Table 43. Yebio Corporation Information
Table 44. Yebio Description and Major Businesses
Table 45. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 46. Yebio Newcastle Disease Vaccine Product
Table 47. Yebio Recent Developments
Table 48. Harbin Veterinary Research Institute Corporation Information
Table 49. Harbin Veterinary Research Institute Description and Major Businesses
Table 50. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 51. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 52. Harbin Veterinary Research Institute Recent Developments
Table 53. Merck Animal Health Corporation Information
Table 54. Merck Animal Health Description and Major Businesses
Table 55. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 56. Merck Animal Health Newcastle Disease Vaccine Product
Table 57. Merck Animal Health Recent Developments
Table 58. DHN Corporation Information
Table 59. DHN Description and Major Businesses
Table 60. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 61. DHN Newcastle Disease Vaccine Product
Table 62. DHN Recent Developments
Table 63. Zoetis Corporation Information
Table 64. Zoetis Description and Major Businesses
Table 65. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 66. Zoetis Newcastle Disease Vaccine Product
Table 67. Zoetis Recent Developments
Table 68. ChengDu Tecbond Corporation Information
Table 69. ChengDu Tecbond Description and Major Businesses
Table 70. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 71. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 72. ChengDu Tecbond Recent Developments
Table 73. Elanco (Lohmann) Corporation Information
Table 74. Elanco (Lohmann) Description and Major Businesses
Table 75. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 76. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 77. Elanco (Lohmann) Recent Developments
Table 78. FATRO Corporation Information
Table 79. FATRO Description and Major Businesses
Table 80. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 81. FATRO Newcastle Disease Vaccine Product
Table 82. FATRO Recent Developments
Table 83. CAVAC Corporation Information
Table 84. CAVAC Description and Major Businesses
Table 85. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 86. CAVAC Newcastle Disease Vaccine Product
Table 87. CAVAC Recent Developments
Table 88. Vaksindo Corporation Information
Table 89. Vaksindo Description and Major Businesses
Table 90. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 91. Vaksindo Newcastle Disease Vaccine Product
Table 92. Vaksindo Recent Developments
Table 93. Newcastle Disease Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 94. United States Newcastle Disease Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 95. Newcastle Disease Vaccine Market Opportunities & Trends in United States Market
Table 96. Newcastle Disease Vaccine Market Drivers in United States Market
Table 97. Newcastle Disease Vaccine Market Restraints in United States Market
Table 98. Newcastle Disease Vaccine Raw Materials
Table 99. Newcastle Disease Vaccine Raw Materials Suppliers in United States Market
Table 100. Typical Newcastle Disease Vaccine Downstream
Table 101. Newcastle Disease Vaccine Downstream Clients in United States Market
Table 102. Newcastle Disease Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Newcastle Disease Vaccine Segment by Type
Figure 3. Newcastle Disease Vaccine Segment by Application
Figure 4. United States Newcastle Disease Vaccine Market Overview: 2020
Figure 5. United States Newcastle Disease Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Newcastle Disease Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Newcastle Disease Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Newcastle Disease Vaccine Revenue in 2020
Figure 9. Live Vaccines Product Picture
Figure 10. Killed Vaccines Product Picture
Figure 11. By Type - United States Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Newcastle Disease Vaccine Price (USD/K Doses), 2016-2027
Figure 14. Chicken
Figure 15. Duck & Goose
Figure 16. Other
Figure 17. By Application - United States Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 18. By Application - United States Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 19. By Application - United States Newcastle Disease Vaccine Price (USD/K Doses), 2016-2027
Figure 20. Merial Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. CEVA Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. QYH Biotech Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Ringpu Biology Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Yebio Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Merck Animal Health Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. DHN Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Zoetis Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. ChengDu Tecbond Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Elanco (Lohmann) Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. FATRO Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. CAVAC Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Vaksindo Newcastle Disease Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. United States Newcastle Disease Vaccine Production Capacity (M Doses), 2016-2027
Figure 35. Newcastle Disease Vaccine Industry Value Chain
Figure 36. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs